# SCIENT

> SCIENT is a privately held, Philadelphia-based communications and creative agency focused on biotechnology and healthcare. Founded by Michael Lampe, it combines senior-level strategic counsel with media relations, scientific storytelling, branding, websites, investor communications, issues management, and milestone support. Its distinctive method begins with the business outcome - financing, partnership, patient engagement, talent, or credibility - then works backward to the message and medium most likely to move the relevant audience.

- **Founded:** 2011
- **Headquarters:** Philadelphia, United States
- **Founders:** Michael Lampe (Founder & CEO)
- **Products:** Strategic communications, Scientific and data storytelling, Brand and digital presence, Communications readiness and execution
- **Notable:** Built a published portfolio spanning more than 40 biotechnology, pharmaceutical, and patient-advocacy organizations., Created award-recognized website and brand work for Larkspur Biosciences, Kynexis Therapeutics, and Precede Biosciences., Expanded from strategic communications into an integrated brand, design, digital, and scientific-storytelling offer.

## Products & services

- **Strategic communications** — Positioning, narrative development, media relations, data and milestone support, investor communications, issues management, thought leadership, executive visibility, employee engagement, advocacy relations, and FDA approval support.
- **Scientific and data storytelling** — Science writing, explanatory graphics, message architecture, and audience-specific narratives that preserve technical accuracy while improving comprehension.
- **Brand and digital presence** — Company naming, visual identity, website design and development, UI/UX, social media kits, animation, video, scientific posters, and print collateral.
- **Communications readiness and execution** — Preparation for financings, clinical and regulatory milestones, transactions, crises, launches, speaking opportunities, and other moments when a coherent company story must travel quickly.

## Achievements

- Built a published portfolio spanning more than 40 biotechnology, pharmaceutical, and patient-advocacy organizations.
- Created award-recognized website and brand work for Larkspur Biosciences, Kynexis Therapeutics, and Precede Biosciences.
- Expanded from strategic communications into an integrated brand, design, digital, and scientific-storytelling offer.
- Established offices or listed locations in both Philadelphia and Boston while operating as a fully remote team.

## Latest updates

- **2026-02** — SCIENT published communications takeaways from the 2026 J.P. Morgan Healthcare Conference, focusing on China's growing role, GLP drugs, and financing pressure on startups.
- **2026-01** — The firm highlighted its work with Prolynx around a $70 million Series A and a new CEO appointment.
- **2026-01** — SCIENT supported PsiThera as it announced a $47.5 million Series A, a CEO appointment, and plans to advance oral biologics.
- **2025-11** — SCIENT marked the completion of client Tourmaline Bio's acquisition by Novartis.
- **2025-11** — The firm highlighted client Bexorg's $23 million Series A for an AI and human-brain-biology drug-discovery platform.

## Links

- Website: https://www.scientpr.com/
- LinkedIn: https://www.linkedin.com/company/scientpr
- Twitter/X: https://twitter.com/scientpr

---

Profile page: https://yespress.io/scient
Published by YesPress — https://yespress.io
Last updated: 2026-09-21